Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).

Creators

• Clerico, M
• Schiavetti, I
• De Mercanti, SF
• Piazza, F
• Gned, D
• Brescia Morra, V
• Lanzillo, R
• Ghezzi, A
• Bianchi, A
• Salemi, G
• Realmuto, S
• Sola, P
• Vitetta, F
• Cavalla, P
• Paolicelli, D
• Trojano, M
• Durelli, L.
• SORMANI, MARIA PIA

Contributors